IPO Price History
Closed
Symbiotec Pharmalab Ltd. logo

Symbiotec Pharmalab Ltd. IPO

Mainboard IPOListedSYMBIOTECBSE, NSE
Current Market Price (CMP)
₹1,164.20(+17.83%)
Sector: Pharmaceuticals & Drugs
Current Price (CMP)
₹1,164.20(+17.83%)

Live Market Quote

Listing Price & Gain
₹1,097.70(+11.10%)

Day 1 Exchange Open

IPO Issue Price
₹988

Band: ₹938 - ₹988

Total Subscription
71.26x

Overall Bid Demand

Total Issue Size
₹1,757 Cr

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
24 Aug 2026
IPO Bidding Closes
27 Aug 2026
Allotment & Refunds
28 Aug 2026
Exchange Listing Day
01 Sept 2026

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 71.26x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)172.03x
Non-Institutional Investors (NII / HNI)73.63x
Retail Individual Investors (RII)12.96x
Employees Reservation15.41x
Total Subscription71.26x
Updated as on 27-Aug-2026 19:00:00

Listing Day & Return Performance

Listing Day Gain+11.10%
₹988 (Issue) → ₹1,097.70 (List)
Per share profit: +₹109.70
Holding Return (Till Date)+17.83%
₹988 (Issue) → ₹1,164.20 (CMP)
Net gain per share: +₹176.20
Post-Listing Performance (Listing Day → Today):+6.06%

About Symbiotec Pharmalab Ltd. IPO

Symbiotec Pharmalab Ltd. is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 24 Aug 2026 and concluded on 27 Aug 2026, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹938 - ₹988. The aggregate issue size was approximately ₹1,757 crore. The company operates primarily within the Pharmaceuticals & Drugs sector.

During the bidding window, Symbiotec Pharmalab Ltd. witnessed heavy demand with an overall subscription of 71.26 times. Institutional investors (QIB) subscribed 172.03x, non-institutional high-net-worth investors (NII) subscribed 73.63x, and retail individual investors (RII) bid 12.96x their reserved quota, alongside employee participation of 15.41x.

The equity shares of Symbiotec Pharmalab Ltd. officially debuted on the stock exchanges on 01 Sept 2026 at an opening listing price of ₹1,097.70, delivering a listing day return of +11.10% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,164.20, representing an overall gain of +17.83% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Symbiotec Pharmalab Ltd. IPO?
The issue price of Symbiotec Pharmalab Ltd. IPO was fixed at ₹988 per equity share. The indicative bidding price band was ₹938 - ₹988.
What was the total issue size of Symbiotec Pharmalab Ltd. IPO?
The total issue size of Symbiotec Pharmalab Ltd. IPO was approximately ₹1,757 crore.
What were the open, close, and listing dates for Symbiotec Pharmalab Ltd. IPO?
Symbiotec Pharmalab Ltd. IPO opened on 24 Aug 2026, closed on 27 Aug 2026, listed on 01 Sept 2026.
How much was Symbiotec Pharmalab Ltd. IPO subscribed?
The IPO received an overall subscription of 71.26 times. Category-wise, QIBs subscribed 172.03x, NIIs subscribed 73.63x, and Retail investors subscribed 12.96x.
What was the listing price and listing gain of Symbiotec Pharmalab Ltd. IPO?
Symbiotec Pharmalab Ltd. IPO listed on the stock exchange at ₹1,097.70, delivering a listing gain of 11.10% compared to the IPO issue price of ₹988.
Is Symbiotec Pharmalab Ltd. IPO a Mainboard or SME IPO?
Symbiotec Pharmalab Ltd. IPO is a Mainboard IPO listed on the main exchange of BSE, NSE.
What is the current return of Symbiotec Pharmalab Ltd. IPO since its IPO?
At the latest market quote of ₹1,164.20, Symbiotec Pharmalab Ltd. IPO has generated an all-time return of +17.83% since its initial public offering.

Related Mainboard IPOs (2026)

AONESTEELS
A-One Steels India Ltd.
₹405+12.35%
ARMEE
ArMee Infotech Ltd.
₹100+275.00%
VARMORA
Varmora Granito Ltd.
₹148+4.73%
SONA
Sonaselection India Ltd.
₹99+3.34%